105 results on '"Novitsky, Vladimir A."'
Search Results
2. Improving Production Management and Control with Intelligent Chatbot Services
3. Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study
4. 2899. Integrating HIV Partner Services and Molecular Epidemiology Data to Enhance HIV Transmission Disruption in Rhode Island: Findings from a Public Health-Academic Partnership
5. 2322. Challenges Faced by Perinatally-Infected Young People Living with HIV in Kenya During the COVID-19 Pandemic
6. Integrating HIV Cluster Analysis in Routine Public Health Prevention Efforts: Lessons Learned from a Statewide Public Health – Academic Partnership
7. 2068. Molecular and Clinical Features of New HIV-1 diagnoses in Northern Dominican Republic
8. 1270. HIV Drug Resistance and Viral Outcomes after 2nd-line Antiretroviral Failure in Kenya
9. 1100. SARS-CoV-2 Seroprevalence in Kenyan Youth living with HIV
10. 1896. Statewide Genomic Surveillance of SARS-CoV-2 Variants in Rhode Island
11. 1271. HIV-1 Drug Resistance in Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Rhode Island, USA
12. 315. Standardized Measurement of SARS-CoV-2 Viral Load Over Time in Respiratory Compartments and in Response to Remdesivir Treatment
13. The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes
14. Author response: Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/Ya Tsie trial
15. HIV Drug Resistance and Transmission Networks Among a Justice-Involved Population at the Time of Community Reentry in Washington, D.C.
16. Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population
17. Limited HIV-1 Subtype C nef 3′PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana
18. Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana
19. Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum]
20. Prevention of HIV Infection in the Absence of a Vaccine
21. HIV Replication
22. Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana
23. Challenges in evaluating the use of viral sequence data to identify HIV transmission networks for public health
24. Joint penalized spline modeling of multivariate longitudinal data, with application to HIV‐1 RNA load levels and CD4 cell counts
25. Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda
26. Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination
27. 885. HIV-1 Treatment Failure and Extensive Drug Resistance in Perinatally Infected Children Failing First-Line Antiretroviral Therapy in Western Kenya
28. Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP)
29. Genetic diversity of Mycobacterium tuberculosis strains circulating in Botswana
30. Correction for Ojwach et al., “Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection”
31. The Changing Epidemiological Profile of HIV-1 Subtype B Epidemic in Ukraine
32. Ethical considerations in global HIV phylogenetic research
33. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection
34. Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana
35. A1 Pairwise diversity and tMRCA as potential markers of HIV infection recency
36. High HIV-1 RNA Among Newly Diagnosed People in Botswana
37. Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa
38. LOW FALSE RECENT RATE OF LIMITING ANTIGEN AVIDITY ASSAY COMBINED WITH HIV-1 RNA DATA IN BOTSWANA
39. Pairwise diversity and tMRCA as potential markers for HIV infection recency
40. Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana
41. Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable
42. Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana
43. Prognostic Value of HIV-1 RNA on CD4 Trajectories and Disease Progression Among Antiretroviral-Naive HIV-Infected Adults in Botswana: A Joint Modeling Analysis
44. Identifying Recent HIV Infections: From Serological Assays to Genomics
45. A Generalized Entropy Measure of Within-Host Viral Diversity for Identifying Recent HIV-1 Infections
46. Viral Genetic Linkage Analysis in the Presence of Missing Data
47. Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: Association with disease progression and influence of immune pressure
48. HIV-1 pol Diversity among Female Bar and Hotel Workers in Northern Tanzania
49. Linkage of Viral Sequences among HIV-Infected Village Residents in Botswana: Estimation of Linkage Rates in the Presence of Missing Data
50. Evaluation of the False Recent Classification Rates of Multiassay Algorithms in Estimating HIV Type 1 Subtype C Incidence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.